OCM
One Capital Management Portfolio holdings
AUM
$2.88B
1-Year Return
11.58%
This Quarter Return
-2.54%
1 Year Return
+11.58%
3 Year Return
+46.98%
5 Year Return
+71.25%
10 Year Return
+135.77%
AUM
$279M
AUM Growth
+$31.3M
(+13%)
Cap. Flow
+$38.4M
Cap. Flow
% of AUM
13.76%
Top 10 Holdings %
Top 10 Hldgs %
31.52%
Holding
598
New
455
Increased
38
Reduced
69
Closed
6
Top Buys
Top Sells
| 1 |
Graham Holdings Company
GHC
|
$7.18M |
| 2 |
AGN
Allergan plc
AGN
|
$2.54M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
$2.01M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
$760K |
| 5 |
iShares Russell 2000 ETF
IWM
|
$214K |
Sector Composition
| 1 | Healthcare | 6.05% |
| 2 | Technology | 5.56% |
| 3 | Financials | 5.28% |
| 4 | Energy | 3.49% |
| 5 | Materials | 3.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
MGE Energy Inc
MGEE
$3.11B
| $149K | 0.05% |
+4,000
| New | +$149K |
|
|
PDCO
152
DELISTED
Patterson Companies, Inc.
PDCO
| $149K | 0.05% |
+3,600
| New | +$149K |
|
153
SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.48B
| $147K | 0.05% |
+3,590
| New | +$147K |
|
154
Vanguard Large-Cap ETF
VV
$44.7B
| $147K | 0.05% |
1,626
-1,839
| -53% | -$166K |
|
155
Cencora
COR
$56.7B
| $141K | 0.05% |
+1,825
| New | +$141K |
|
156
AbbVie
ABBV
$376B
| $140K | 0.05% |
+2,421
| New | +$140K |
|
157
Healthpeak Properties
DOC
$12.5B
| $139K | 0.05% |
+3,843
| New | +$139K |
|
|
SIAL
158
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $136K | 0.05% |
+1,000
| New | +$136K |
|
159
Abbott
ABT
$231B
| $135K | 0.05% |
+3,240
| New | +$135K |
|
|
MLNX
160
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $135K | 0.05% |
+3,000
| New | +$135K |
|
|
MON
161
DELISTED
Monsanto Co
MON
| $133K | 0.05% |
+1,181
| New | +$133K |
|
162
Charles Schwab
SCHW
$177B
| $131K | 0.05% |
+4,470
| New | +$131K |
|
163
Mastercard
MA
$538B
| $129K | 0.05% |
+1,750
| New | +$129K |
|
|
UHT
164
Universal Health Realty Income Trust
UHT
$568M
| $125K | 0.04% |
+3,000
| New | +$125K |
|
165
ConocoPhillips
COP
$120B
| $124K | 0.04% |
+1,624
| New | +$124K |
|
166
GSK
GSK
$79.8B
| $123K | 0.04% |
+2,142
| New | +$123K |
|
167
Quest Diagnostics
DGX
$20.1B
| $121K | 0.04% |
+2,000
| New | +$121K |
|
168
Nike
NKE
$111B
| $120K | 0.04% |
+2,680
| New | +$120K |
|
169
Deere & Co
DE
$128B
| $116K | 0.04% |
+1,412
| New | +$116K |
|
170
Qualcomm
QCOM
$172B
| $116K | 0.04% |
+1,553
| New | +$116K |
|
171
Cigna
CI
$81.2B
| $113K | 0.04% |
+1,241
| New | +$113K |
|
172
iShares S&P 500 Growth ETF
IVW
$63.7B
| $109K | 0.04% |
+4,092
| New | +$109K |
|
173
Citigroup
C
$179B
| $105K | 0.04% |
+2,033
| New | +$105K |
|
174
O-I Glass
OI
$1.95B
| $104K | 0.04% |
+4,000
| New | +$104K |
|
175
Vanguard Value ETF
VTV
$144B
| $104K | 0.04% |
+1,275
| New | +$104K |
|